Evidence map›Paper›PMID 37158880›Full record

ArticleProteome science2023

Purification and proteomic analysis of potent fibrinolytic enzymes extracted from Lumbricus rubellus.

Laurentia Stephani, Puji Rahayu, Debbie Retnoningrum, Maggy Thenawidjaja Suhartono, Heni Rachmawati, Raymond R Tjandrawinata

Open access · goldAbstract read
In one paragraph

Article in Proteome science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Lumbrokinase Extracted fromBiomolecules · 2024
    Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Laurentia StephaniBiopharmaceutical Technology Division, Research Innovation and Invention, Dexa Laboratories of Biomolecular Sciences, PT Dexa Medica, Kawasan Industri Jababeka II, Industri Selatan V Block PP No. 7, Cikarang, 17550, Indonesia.
Puji RahayuBiopharmaceutical Technology Division, Research Innovation and Invention, Dexa Laboratories of Biomolecular Sciences, PT Dexa Medica, Kawasan Industri Jababeka II, Industri Selatan V Block PP No. 7, Cikarang, 17550, Indonesia.
Debbie RetnoningrumResearch Group of Pharmaceutics, School of Pharmacy, Bandung Institute of Technology, Bandung, Indonesia.
Maggy Thenawidjaja SuhartonoDepartment of Food Science and Technology, Bogor Agricultural University, Fateta Building, Kampus IPB Darmaga, Bogor, Indonesia.
Heni RachmawatiResearch Group of Pharmaceutics, School of Pharmacy, Bandung Institute of Technology, Bandung, Indonesia.
Raymond R TjandrawinataBiopharmaceutical Technology Division, Research Innovation and Invention, Dexa Laboratories of Biomolecular Sciences, PT Dexa Medica, Kawasan Industri Jababeka II, Industri Selatan V Block PP No. 7, Cikarang, 17550, Indonesia. raymond@dexa-medica.com.
Bandung Institute of Technology · IDAtma Jaya Catholic University of Indonesia · IDIPB University · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLumbrokinase derived from earthworms, Lumbricus rubellus is known to have fibrinolytic enzymes that have potential as therapeutic drugs due to its ability to dissolve fibrin. The current study is aimed to purify the Lumbrokinase from L. rubellus and identify its protein component.

methodsWater extract of local earthworm Lumbricus rubellus revealed several proteins. Therefore, to identify its protein component, purification through HiPrep DEAE fast flow and proteomic analysis were conducted prior to identifications. A combination of two-dimension gel electrophoresis (2DE) and electrospray ionization mass spectrometry analysis was used to identify the purified fractions.

resultsThe purified fractions contain five protein bands, namely F25-1, F25-2, F85-1, F85-2, and F85-3, which displayed strong fibrinogenolytic activity. F25 fractions showed fibrinogenolytic activity of 974.85 U/mg, while F85 fractions showed higher activity of 1,484.11 U/mg. Fractions F85-1, F85-2, and F85-3 showed molecular weights of 42.6 kDa, 27.03 kDa, and 14 kDa, respectively and were identified as Lumbrokinase iso-enzymes.

conclusionThis preliminary study indicates that the F25 and F85 fractions are similar to published fibrinolytic protease-1 and lumbrokinase, respectively, in terms of their amino acid sequence.

Indexed as

DLBS1033Earthworms fibrinolytic enzymeLumbricus rubellusLumbrokinaseProtein purification

Identifiers

PMID37158880
PMCPMC10165752
OpenAlexW4375956095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.